These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 182347)

  • 1. Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
    Seal US; Doe RP; Byar DP; Corle DK
    Cancer; 1976 Sep; 38(3):1095-107. PubMed ID: 182347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
    Seal US; Doe RP; Byar DP; Corle DK
    Cancer; 1976 Sep; 38(3):1108-17. PubMed ID: 182348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
    Seal US; Doe RP; Byar DP; Corle DK
    Cancer; 1978 Oct; 42(4):1720-9. PubMed ID: 213184
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
    Blackard CE; Byar DP; Seal US; Doe RP
    N Engl J Med; 1974 Oct; 291(15):751-5. PubMed ID: 4369891
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic effects of oestrogen treatment in patients with carcinoma of prostate: a comparison of stilboestrol and conjugated equine oestrogens.
    Shahmanesh M; Bolton CH; Feneley RC; Hartog M
    Br Med J; 1973 Jun; 2(5865):512-4. PubMed ID: 4736626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma.
    Sinha AA; Blackard CE; Seal US
    Cancer; 1977 Dec; 40(6):2836-50. PubMed ID: 201356
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen on the serum cholesterol and triglyceride levels of prostatic cancer patients.
    Kontturi M; Sotaniemi E
    J Urol; 1971 Jun; 105(6):847-9. PubMed ID: 4997080
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipid levels and thromboembolic complications during estrogen therapy of prostatic cancer.
    Sotanieme EA; Kontture MJ
    Scand J Urol Nephrol; 1975; 9(2):89-93. PubMed ID: 1145147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of breast cancer with medroxyprogesterone acetate.
    Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
    Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive effects of conjugated equine estrogen on triglyceride metabolism in oophorectomized women based on a stratification analysis of pretreatment values.
    Hashimoto K; Nozaki M; Nakano H
    Fertil Steril; 2004 Apr; 81(4):1041-6. PubMed ID: 15066461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women.
    Krauss RM; Perlman JA; Ray R; Petitti D
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1606-11. PubMed ID: 2837088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
    Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
    J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.